Skip to main content
Year archive

ADHERIUM LIMITED — 2023 filings

All 55 regulatory filings released by ADHERIUM LIMITED (ADR) in 2023, sourced directly from the official regulator.

55 Filings
2023 Period
2023 filings (55)
Filing Released Lang
First Order of Hailie Sensors to US Intermountain Health 2 pages 143.5KB
Capital/Financing Update
2023-12-17 English
Completion of Share Consolidation 1 page 110.3KB
Share Issue/Capital Change
2023-12-06 English
Production and US Market Release of Advanced Smartinhaler 2 pages 146.5KB
Regulatory Filings
2023-12-03 English
Amended Constitution 54 pages 574.3KB
Governance Information
2023-11-30 English
Securities Incentive Plan 27 pages 493.0KB
Governance Information
2023-11-30 English
CEO Presentation to the Annual General Meeting 18 pages 1.6MB
AGM Information
2023-11-29 English
Results of Meeting & Approval of Share Consolidation 2 pages 240.3KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-29 English
Monsoon Twilight Investor Briefing Presentation 17 pages 2.9MB
Investor Presentation
2023-11-21 English
First Patients Enrolled at SENTA Partners in the US 2 pages 113.3KB
Regulatory Filings
2023-11-20 English
Application for quotation of securities - ADR 6 pages 28.3KB
Share Issue/Capital Change
2023-11-13 English
Cleansing Notice 1 page 74.3KB
Share Issue/Capital Change
2023-11-13 English
Notification of cessation of securities - ADR 4 pages 23.9KB
Share Issue/Capital Change
2023-11-13 English
Notification of cessation of securities - ADR 4 pages 23.9KB
Regulatory Filings
2023-11-08 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 430.0KB
Interim / Quarterly Report
2023-10-30 English
Notice of Annual General Meeting/Proxy Form 28 pages 614.1KB
AGM Information
2023-10-25 English
Letter to Shareholders regarding Annual General Meeting 1
AGM Information
2023-10-25 English
Proposed Consolidation of Capital 2 pages 144.1KB
Capital/Financing Update
2023-10-25 English
Consolidation/Split - ADR 5 pages 28.1KB
Share Issue/Capital Change
2023-10-25 English
Production & market release of new, next generation sensors 3 pages 121.4KB
Capital/Financing Update
2023-10-08 English
First Patients Enrolled at Allergy Partners in the US 2 pages 109.7KB
Regulatory Filings
2023-09-24 English
New Major Asthma Partnership with US-Based SENTA partners 4 pages 146.5KB
Regulatory Filings
2023-09-17 English
Change of Company Address 1 page 93.4KB
Regulatory Filings
2023-08-29 English
Annual Report to shareholders 65 pages 7.5MB
Annual Report
2023-08-29 English
Appendix 4G & Corporate Governance Statement 24 pages 635.8KB
Regulatory Filings
2023-08-29 English
Change of Director's Interest Notice x 3 7 pages 243.6KB
Director's Dealing
2023-08-10 English
Update - Notification of buy-back - ADR 6 pages 26.8KB
Transaction in Own Shares
2023-08-08 English
Notification of buy-back - ADR 5 pages 24.5KB
Transaction in Own Shares
2023-08-07 English
Change in substantial holding 3 pages 93.4KB
Major Shareholding Notification
2023-08-06 English
Accelerating Commercialisation with Largest US A&A Practice 4 pages 171.0KB
Regulatory Filings
2023-08-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 402.1KB
Interim / Quarterly Report
2023-07-27 English
Adherium enters rapid US commercialisation phase 5 pages 414.6KB
Regulatory Filings
2023-07-26 English
Notification of buy-back - ADR 5 pages 24.4KB
Transaction in Own Shares
2023-07-23 English
Resignation of Joint Company Secretary 1 page 95.5K
Board/Management Information
2023-07-05 English
Application for quotation of securities - ADR 7 pages 29.8KB
Share Issue/Capital Change
2023-06-27 English
Change of Auditor 2 pages 100.3KB
Audit Report / Information
2023-06-26 English
Notification of cessation of securities - ADR 5 pages 26.1KB
Share Issue/Capital Change
2023-05-10 English
Change of Company Secretary 2 pages 100.3KB
Board/Management Information
2023-05-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 351.2KB
Interim / Quarterly Report
2023-04-26 English
US FDA clearance of Adherium's Hailie for Teva inhalers 4 pages 312.6KB
Regulatory Filings
2023-03-22 English
Half Yearly Report and Accounts 22 pages 4.5MB
Interim / Quarterly Report
2023-02-26 English
Ceasing to be a substantial holder 3 pages 138.5KB
Major Shareholding Notification
2023-02-26 English
Change in substantial holding 3 pages 175.8KB
Major Shareholding Notification
2023-02-20 English
Becoming a substantial holder 10 pages 58.9KB
Major Shareholding Notification
2023-02-19 English
Ceasing to be a substantial holder 9 pages 140.0KB
Major Shareholding Notification
2023-02-15 English
Adherium Exhibiting at AAAAI 2023 Annual Meeting 2 pages 272.9KB
Regulatory Filings
2023-02-12 English
Becoming a substantial holder 10 pages 331.6KB
Major Shareholding Notification
2023-02-01 English
Adherium launches new Interactive Investor Hub 2 pages 280.2KB
Regulatory Filings
2023-01-31 English
Change in substantial holding 3 pages 172.0KB
Major Shareholding Notification
2023-01-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 326.7KB
Interim / Quarterly Report
2023-01-29 English
Application for quotation of securities - ADR 6 pages 27.7KB
Share Issue/Capital Change
2023-01-24 English
Notification regarding unquoted securities - ADR 5 pages 26.5KB
Share Issue/Capital Change
2023-01-24 English
ADR TGA Approval for Next Generation Sensors 2 pages 109.9KB
Regulatory Filings
2023-01-19 English
Ellipta Production and Market Release 2 pages 275.9KB
Regulatory Filings
2023-01-19 English
Adherium Awarded UK NHS SBRI Healthcare Monitoring Project 2 pages 114.0KB
Capital/Financing Update
2023-01-17 English
Adherium to present at J.P. Morgan Healthcare Conference 19 pages 1.6MB
Investor Presentation
2023-01-09 English